-
International Journal of Wine Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Resveratrol comes of age
Perspectives
(3888) Views (932) Full article downloads
Authors: Roger M Pinder
Published Date July 2010
Volume 2010:2 Pages 43 - 44
DOI: http://dx.doi.org/10.2147/IJWR.S8572
Roger M PinderInternational Journal of Wine Research, York, UK
There is substantial evidence that moderate consumption of alcohol is associated with a lower risk of mortality,1,2 cardiovascular disease,3 stroke,4 type 2 diabetes,5,6 and cognitive decline and dementia in old age.7–9 It is still not proven whether wine consumption is associated with lower risks than consumption of other forms of alcohol such as beer or distilled spirits, but systematic reviews suggest that this may be the case at least for cognitive decline and dementia.7,10 However, a causal relationship has been questioned by some, with suggestions that health status and social factors may confer the benefits,11,12 especially for wine drinkers who are more often female, better educated, health conscious, non-smokers and temperate drinkers.13 Nevertheless, plausible biological mechanisms explain the benefits of alcohol and wine, and the relative specificity of the inverse relationship of moderate drinking to various human ailments is a strong point for causality.10
Other articles by Dr Roger Pinder
Biodiversity of wine grapes: less than we thought
Does wine prevent dementia?
Editorial Foreword: International Journal of Wine Research
More on the benefits of wine for cognitive decline and dementia
Readers of this article also read:
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Alcohol-attributable cancer: fact or fiction?
Biodiversity of wine grapes: less than we thought
More on the benefits of wine for cognitive decline and dementia
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Does wine prevent dementia?
- Wine consumers’ environmental knowledge and attitudes: Influence on willingness to purchase
- China’s role in global competition in the wine industry: A new contestant and future trends
- Mycoflora and production of wine from fruits of soursop (Annona Muricata L.)




